Search

Author/Creator Barraco, M.

1. Addition of Lenalidomide to Azacitidine in Higher Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study. (April 2017)

Authors:
Finelli, C.; Clissa, C.; Follo, M.; Barraco, M.; Mongiorgi, S.; Avanzini, P.; Bosi, C.; Castagnari, B.; Candoni, A.; Crugnola, M.; Giannini, M.B.; Gobbi, M.; Leonardi, G.; Rigolin, G.M.; Russo, D.; Tosi, P.; Pellagatti, A.; Boultwood, J.; Cocco, L.; Cavo, M.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna. (April 2017)

Authors:
Follo, M.Y.; Pellagatti, A.; Armstrong, R.N.; Mongiorgi, S.; Astolfi, A.; Indio, V.; Ratti, S.; Clissa, C.; Barraco, M.; Parisi, S.; Manzoli, L.; Pession, A.; Cocco, L.; Boultwood, J.; Finelli, C.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S54
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search